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Article Information  ABSTRACT 
Received: 19th June 2018  Wound is an injury of living tissue or break in the epithelial integrity of the upper layer of skin. 
This may lead to disturbance of skin anatomical structure and their function. The normal wounds 
start to heal immediately after an injury. Normal healing process involved: inflammatory phase, 
proliferation phase and maturation phase. Now a day wound healing is a challenging clinical 
problem. So, necessity of effective wound management is required. The various screening 
models play important role to understand the basic process of tissue repair and treatment of 
wounds. Wide varieties of in-vitro, ex-vivo and in-vivo models have been developed for 
evaluation of wound healing activity. The in-vitro models includes Chick chorioallantoic 
membrane assay, Fibroblast assay, Collagen assay, Scratch assay, Endothelial cell in vitro tube 
formation assay, Keratinocytes assay. Ex-vivo models includes organotypic culture, human ex 
vivo skin culture, porcine model, Human organotypic skin explanted culture and the  in-vivo 
models includes Excision wound model, Incision wound Model, Burn wound model, Dead space 
wound model.The aim of this review article is detailed study of different types of in-vitro, ex-
vivo and in-vivo models for evaluation of wound healing activity. 
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INTRODUCTION 
A wound can be defined as an injury of living tissue or break in 
the epithelial integrity of the upper layer of skin. This may 
cause to disturbance of skin anatomical structure and their 
function. 
Mechanism of wound healing 
The normal wounds are starts to heal instantly after an injury, 
but in some cases wounds failed to heal in an appropriate and 
organized manner. These types of wounds required to continue 
management. The normal wound healing process are-
Inflammatory phase, Proliferative phase and Maturation phase 
[3]. The inflammatory phase arises between few minutes to up 
to 24 minutes after injury. Homeostasis is a first step of wound 
healing. In this phase many extrinsic and intrinsic coagulation 
factors will activated within minutes of injury, this may leads 
to degranulation and releasing chemotactic factors 
(chemokine’s) and growth factors (GFs) which may help to the 
formation of clots [4].The second steps of the inflammatory 
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phase are neutrophils, is the first cells to appear at the injury 
site, for cleanse waste and bacteria to provide a good 
environment for wound healing. The last step of inflammatory 
phase is macrophage, the most important cells act as the key 
regulatory cells for repair. Macrophages accumulate and 
facilitate phagocytosis of bacteria and damage tissue. 
Macrophages initiate two important aspects of healing such as 
angiogenesis and fibroplasia. They are essential for providing 
the metabolic needs of the healing process [5, 6]. The 
proliferative phase starts at 3 day of wounding and last up to 2–
4 weeks. In stage of macrophage the Fibroblast-stimulating 
factor are activated. They released fibroblasts. Fibroblasts act 
as the key cellsof the proliferative phase, When activation of 
fibroblast they produced Collagen and proteoglycans and 
subsequently effects on remodeling of the granulation tissue. 
Granulation tissue increase wound tensile strength and reduces 
size of the wounded-epithelialization is important for wound 
healing [7]. The last stage of wound healing is maturation or 
remodeling phase. Maturation phase completed around 2 year. 
It depends on continuous collagen synthesis. The contraction 
rate and regular increase in tensile strength are seen in this 
phase [8, 9]. 
 
Fig. 1- Types of wound 
 
 
Fig. 2 Natural pathway for wound healing 
DIFFERENT MODELS FOR WOUND HEALING 
In-vitro Studies 
The term in-vitro is derived from Latin phrase which means 
“the technique which performed outside the living animal”. In 
this type of study the tissue are removed from animal body and 
preserved for few days to several months in the suitable growth 
medium. The in-vitro assay is useful for determination of 
antimicrobial effects and healing enhancing agents [10]. 
Chick chorioallantoic membrane assay: The wound healing 
agents produce angiogenesis. It stimulates new vessels 
formation in CAM model. The angiogenesis process is 
essential for wound healing. They provide the re-establishment 
of normal blood flow and tissue repaired [11]. In this model 
collect nine day-old fertilized chick eggs and small window 
(1.0 cm
2
) is made on the surface of shell.  Hole is created for 
air space then air is sucked out through rubber bulb. The 
window is open and methylcellulose is fixed with test sample 
placed at the joint of two large vessels. The window is resealed 
by tape and eggs are incubated at 37
○
C in a well-humidified 
chamber for 72 h. The eggs are open and observe new vessel 
 
Open wound                   
Blood releases from the 
body & bleeding is 
clearly visible 
 
Closed wound  
Blood is discharge from 
the vascular system but 
remains in the body 
 
Chronic wound  
In case of chronic wound it 
failed to recover through 
normal healing pathway. 
Acute wound  
this types of wound repaired 
themselves by using normal healing 
pathway from 5-10 day or  in 30 days. 
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formation. Compared eggs disk containing drug or without 
drug. FGF (Fibroblast Growth Factor) are used as a standard 
[12]. 
 
Fibroblast assay: Fibroblast assay are used for the 
determination of the total protein of viable cells present by 
staining with an appropriate dye such as sulforhodamine B 
(SRB) or neutral red. 
In fibroblast assay, fibroblasts are activate and secreted 
collagens and subsequently effect on remodeling of the 
granulation tissue on woundarea. In this model the Cells are 
incubate in an atmosphere of CO2, air at 37
○
C in a tissue 
culture incubator, and suspended at viable cells in the growth 
media (DMEM). The suspended cells are fertilized with FCS 
(fetal calf serum) and allowed to equilibrium for 3 d. 
individually test and standard drug is introduced in medium on 
3
th 
day. In 9
th 
day media is changed and wash with phosphate 
buffered saline solution. Cells are divided into two parts. One 
part used for hydroxyproline content assay and the second one 
is DNA. The cells capability is determining by trepan blue [13]. 
 
Keratinocytes assay: Keratinocytes provide covering of 
epidermal layer and prevents fluid loss and delays bacterial 
attacks. Keratinocytes cell is incubated with serum-free 
keratinocyte growth medium (KGM) at 37
○
C temp with CO2. 
Vascular permeability factor (VPF) cells are subculture in 24-
well plates. After overnight culture the media is replaced with 
fresh KGM. At intervals the medium is collected and extract 
cell lyser with lysis buffer samples are centrifuge and store 
(70°C) for immunoassay [14, 15]. 
 
Collagen assay: The presences of TGF-3 (Transforming 
growth factor type-3) in cells or cell fragments play some 
intrinsic role in inflammation and tissue repair. In this assay the 
NRK 49 F cells are seed in Dulbecco’s modified Eagle's 
medium (DMEM) /calf serum. After the cell sreach confluence, 
the medium is change to minimal essential medium (MEM) 
(containing glutamine, Hepes buffer, and plasma-derived 
serum), and growth factors is add HCl containing bovine serum 
albumin. After 16h the media is changed to ascorbate and other 
supplements, but without plasma. Growth factors are re-added. 
After 15 min, proline are added and incubate continue for 3h at 
37
○
C. Collagen is determined on the Poole medium from 
triplicate wells using bacterial collagenase [16,17] 
 
Scratch assay: This method is based on formation of 
‘‘scratch’’ on cell monolayer. The cells on the edge of the 
newly formed gap are move toward the opening to closing the 
‘‘scratch’’ until new cell–cell contacts are recognized again 
[18]. The fibroblast L929 (1-104 cells) and keratinocytes 
HaCaT (2-104 cells) are seeded in 24-well cell culture plate. 
Linear scratch is prepared in confluent cell monolayer by using 
pipette slope. Remaining cell is washing out with simple DME 
medium.  The standard drug is used as positive control. The 
cellular gap in the cell monolayer is measured at different time 
intervals [19, 20]. 
 
Endothelial cell in-vitro tube formation assay: Fibrin media 
are prepared by using of thrombin to fibrinogen solution. After 
polymerization, the thrombin is inactivated by incubating in 
HMEC medium. EC (endothelial cell) are seed confluent on the 
surface of each medium. After 16h of attachment the EC are 
stimulate with HMEC media supplement with TNF-α in 
presence or absence of VEGF (vascular endothelial growth 
factor) or bGF (fibrinogen). In final steps the gels are fixed 
with formaldehyde, paraffin-embed. The EC growth into fibrin 
mediums are analyzed by using microscope [21]. 
 
Ex-vivo studies 
The wordex-vivo is derived from Latin word means “out of the 
living”.The study is carried out with an organ or tissue isolated 
from an entireanimal.Ex-vivo models are positively used to 
evaluate epithelization rate after treatment and complete 
molecular information about wound healing [22]. 
 
Human organotypic skin explanted culture (hOSEC): hOSEC 
model are used to evaluate cell migration of skin and 
keratinocyte cytotoxicity, disappearance of keratinocyteand 
RNA are evaluated by this model. Methyl green-pyro nine 
(MGP) stain are used for staining of tissue. Collect skin from 
informed patients suffering from breast or abdomen surgery. 
The tissue is cut (1.0 cm
2
) and cultured in culture medium at 
37
○
C temperature with CO2 and humidified air. The Dulbecco's 
Modified Eagle Medium (DMEM) with Fetal Bovine Serum, 
antibiotic (penicillin, streptomycin and amphotericin B) and L-
glutamine containing medium are used. After culture, the tissue 
are collect and fixed with formalin and inserting with paraffin 
and histology or immunohistochemistry methods are applied 
for determination of cell migration [23, 24]. 
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Porcine model: Porcine model are used to dose-dependent 
calculation of corneoepithelial wound healing. Freshly porcine 
eye are used. In experiments only those eyes used that 
completely show transparent cornea and no signs of injury in 
Excimerlaser operating microscope. Eye is gently rinsed with 
water and removes adhering blood. Basic salt solution at is 
added. Porcine eye dip in tissue-culture medium for 3 min then 
placed in sterile containers to prevent drying of the ocular 
surface. The process was carried out by semi sterile (laminar-
flow) conditions. The 5.0 mm in diameter and 40 mm in depth 
are created on corneal epithelium. After laser treatment the 
eyes are fixed with custom-built support and maintain physical 
intraocular pressure. The transparent cavity are cannulated with 
needle and filled with tissue-culture medium. The ocular 
surface are cleansed by tissue-culture medium and incubated at 
1 h. Test solution are applied. The size of each wound is 
measured by horizontally and vertically in two different 
positions under ultraviolet lights [25]. 
 
Human ex-vivo skin culture (HESC): HESC model are used 
to Detect Keratinocyte Differentiation, Keratinocytes 
Apoptosis and Proliferation rate. Skin is carefully removed 
with blade and disinfected with ethanol solution then fixed with 
sterilized cutting board. A thin layer of epidermis is cut and 
rinse with Dulbecco’s phosphate-buffered saline solution with 
penicillin-streptomycin. It is located on the bottom of nylon 
mesh cell strainer. After fixing of skin the cell culture medium 
is added. The skin graft are cultured in liquid-air interphase and 
kept in cell culture. The cell culture is incubated at 37
○
C with 
CO2. The medium are changed every day. The cultured skin 
grafts are collected at different time intervals and immediately 
fixed with formalin. Fixed tissues are embedded with paraffin 
and divided with 5 mm thickness. Hematoxylin & eosin (H&E) 
solutions are used as strainer to stain tissue section and 
observed under Nikon Eclipse 50i light microscope [26, 27]. 
 
Organotypic culture (OTC): Fibroblasts and liquid collagen 
mixture is add and incubated at 37
○
C for 24 h. keratinocytes 
cell are suspended with E-medium. Medium is altered every 
day till the sample is collected. The skin grafts were collected 
at 12
th
 day of post lifting. The cultured skin scions are collected 
at day 0, 2, 4, 10, 12, 14, and fixed with formalin. The fixed 
tissues are embedded with paraffin and sectioned with 5 mm 
thickness. The tissue section is stain with hematoxylin & eosin 
(H&E) solutions and observed under light microscope [28, 29]. 
In-vivo studies 
The term in-vivo is derived from Latin means “in the living”. It 
can be defined as the test is performed in living organism 
(mice, rat and rabbits etc.) pharmacological effect are same in 
human as in animals due to which non clinical studies in 
animal is required before administration to human.Following 
types of wounds are made in laboratory animals are studied 
[30]. 
 
Excision wound model: In this model the rate of contraction 
and epithelization are determined. Animals are anesthetized 
and shaven back region with shaving cream after that hollow is 
made on the dorsal thoracic region of the animals.  Remove 
300 mm
2 
circular areas with the help of surgical blade and 
scissor. The depth of wound is not more than 2mm. Treatment 
start from the day of operation. Measurement of wound area, 
period of epithelisation, wound index, collagen, estimation of 
protein and hexosamine parameters are studied [31, 32]. 
 
Incision wound Model:  In this model tensile strength are 
measured. Animal is anesthetized with ether or ketamine HCl 
at a specific dose. Back area is shaved. After shaving, 6 cm 
long and 2mm depth incision is prepared with the help of 
surgical blade (No. 9). Wound is sealed by surgical needle (No. 
32) and surgical thread (No. 000). On 7
th
 day sutures is 
removed. After 10
th
 day of post wounding tensile strength is 
evaluated by tensiometer [33]. 
 
Burn wound model: Rate of contraction is determine by burn 
wound model. Animals are anesthetized with local anaesthetic 
agent. burn wound model are divided on the basis of degree of 
wound such as a).first degree wound, b) Second degree burn, c) 
third degree burn (full thickness) [34]. 
a) First degree wound:-First-degree burn are commonly occurs 
in direct contact of flame or intense sunlight in short period. In 
this type of burn only epidermis and Stratum conium are 
injured, and there is no damage in dermis layer.A special metal 
plate 2×2cm with holder is heated to 60
○
C and applied to the 
dorsal area of the animals for 30 s to induce partial thickness 
burn wound. b) Second degree burn: -This type of wound is 
clinically characterised by pain and erythema. The healing of 
wound is depends on the deepness of skin damage and 
infection. wound are made by placing the 90
○
C hot plate on the 
selected dorsal area of the animal for 10 s or hot molten wax  is 
poured into shaven back area  of animal until wax get 
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solidified. Wax is removed and marked with partial thickness 
circular burn [35]. c) Third degree burn is caused by hot water, 
fire and prolonged contact with electrical current. The wound 
area is exhibits tightness and brightness as the elasticity of the 
skin is lost, causing abnormal shrinkage. In such cases, all 
structures of skin are damaged and result is coagulation and 
necrosis of the skin. Metal plate is heated at 100
○
C and applied 
at the dorsal area of the animal for 30 sec.The parameters for 
evaluation of burn wound are wound contraction and period of 
epithelisation [36,37]. 
 
Dead space wound model: Determination of healing potential 
and collagen strength. Polypropylenetube (2.5×0.5 cm) is 
implant on each side of paravertebral lumbar region of the skin 
by subcutaneous route. Wounds are sutured with surgical 
suture. Treatment is start, After 10 day’streatment the 
granulation tissue is formed on the tube. Tissue iscollected 
carefully andbreaking strength of the granulation tissue is 
measured [38, 39]. 
 
CHALLENGES 
In-vitro:-In-vitro models may be useful theoretically but are 
lacking the physical characteristics of the natural human skin. 
These models are unable for determining all the factors 
involved in wound healing [40]. 
 
Ex-vivo:-The major drawback of ex-vivo wound model are 
isolation of tissue, it is a critical steps of ex-vivo model 
requiring careful handling.  
 
In-vivo: -The number of animal used in research purpose is 
increased in day by day. Every year millions of experimental 
animal are used all over the world. Many periods animal 
survive the pain, distress and death during experiments.The 
animal used for research is unethical and needto stop. 
Alternative models are used to overcome the drawback related 
with animal experiment and avoid the incorrect procedure [41, 
42]. 
 
CONCLUSION 
The study of wound healing agents has been an important field 
of research. This review provides effective knowledge about 
various models (in-vitro, ex-vivo and in-vivo) and alternative 
models to evaluate wound healing activity, which may help to 
wound care specialists to understand healing response. 
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